Drug Delivery System Having HSA-Dope Conjugate Micelle
Inventors:
Prof. Swati Biswas , Prof. Balram Ghosh, Ms.Kumari Preeti, Ms. Yamini Bobde
The challenge lies in the limited solubility and loading capacity of curcumin, hindering its therapeutic efficacy and increasing production costs.
The invention introduces a drug delivery system encapsulating curcumin within a human serum albumin (HSA) and 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) conjugate micelle.
The method involves developing a novel drug delivery system comprising HSA-DOPE conjugate micelle encapsulating a lipophilic drug for improved therapeutic outcomes in treating diseases like breast cancer.
Potential Indian Clients: Pharmaceutical companies specializing in oncology treatments, research institutions focusing on cancer therapy, hospitals and clinics offering cancer treatment services
Current TRL: NA
Funded by: NA
IPC: A61K, C07K
Domain: Drug delivery system for cancer treatment
This website uses cookies or similar technologies, to enhance your browsing experience.